Gontivimab (ALX-0171) is a trivalent nanobody targeting the hRSV fusion (F) protein with anti-RSV antiviral properties for the study of respiratory syncytial virus infections.
Purity:
94.40%
CAS Number:
[1257358-38-5]
Target:
RSV
* VAT and and shipping costs not included. Errors and price changes excepted